KeyBanc raised the firm’s price target on Alignment Healthcare (ALHC) to $28 from $21 and keeps an Overweight rating on the shares. 2025 was a difficult year for investors in Healthcare Services, the firm says. KeyBanc thinks 2026 may bring a less positive backdrop for Hospitals and incrementally better backdrop for managed care organizations and value-based care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare appoints Mansour as Chief Digital Officer
- Alignment Healthcare price target raised to $25 from $18.50 at TD Cowen
- Alignment Healthcare price target raised to $21 from $18 at UBS
- Alignment Healthcare: Sustained Membership Growth and Expanding EBITDA Support Buy Rating
- Alignment Healthcare Reports Strong Medicare Advantage Membership Growth